- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Cancer Patients Do Not Demand Inappropriate Intervention, Study Finds
An accompanying editorial by a Fred Hutch researcher says, "The demanding cancer patient looks less like a budget buster and more like an urban myth."
According to a recent study published in JAMA Oncology, medical intervention was demanded or requested by 8.7% of patients with cancer, of which, only 11.4% of requests or demands were deemed inappropriate—contrary to commonly held perceptions by clinicians.
The survey included 3624 unique patients and 60 clinicians, including oncologists, oncology fellows, nurse practitioners, and physician assistants, who practiced at 3 Philadelphia-area hospitals. Immediately following a patient—clinician encounter or after a half-day clinic session, the clinician was privately interviewed by a trained research associate. United States census data from 2010 were used to determine patient socioeconomic status according to zip code.
Link to the complet article on Cancer Therapy Advisor: http://bit.ly/1JKlCpI
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Texas Oncology to Roll Out Canopy for ePROs After Head-to-Head Pilot
March 18th 2025Debra Patt, MD, PhD, MBA, executive vice president of Public Policy and Strategy for Texas Oncology, said the practice received positive feedback from nurses and patients during a pilot that concluded in February.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
